Renaissance Laser and Vein Institute offers the latest Laser Vein Treatments to eliminate varicose and spider veins. Leg veins fall in one of three categories that define their size and severity: varicose veins, reticular veins or spider veins, all of which can receive medical vein treatment. Unfortunately, all three types of veins can become increasingly prominent and unsightly as people age, resulting in dark blue and red lines that are visible through the skin. Though covering up the veins might work in the beginning, varicose veins and spider veins tend to get worse over time and require true medical vein treatment to eliminate the problem.
Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced that on September 30th, 2009 the FDA issued a 510K to Lumenis stating that the PolyScope Flexible Endoscope can now be sold in the United States.
Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.
Doctors at the annual meeting of the American Society for Reproductive Medicine got a glimpse into the future of women's health with the presentation of endoscopic gynecologic surgery performed for the first time using "4K" technology.
Materials characterization company Malvern Instruments (Malvern, Worcs, UK) and Kaiser Optical Systems (Ann Arbor, MI, USA), a leading supplier of Raman analyzers and components for spectroscopy, announce a development collaboration that will enhance the product portfolios of both companies. As part of the process of bringing the resulting new products to market, both companies will be seeking the involvement of potential customers at the final stages of product development and for beta evaluations later this year.
A Denver ophthalmologist recently became the first in Colorado to implant a special type of lens during cataract surgery, raising the bar for patient care in the state while increasing the quality of life for his patients.
Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nutritional component of the eye, which may afford protection against the development and/or progression of age-related macular degeneration (AMD). The study, conducted by leading ophthalmology and vision researchers from the Macular Pigment Research Group at the Waterford Institute of Technology, is published in the October 2009 issue of the high impact journal Investigative Ophthalmology & Visual Science (IOVS).
AMD LASERS, the world leader in comprehensive and affordable laser technology, today announced a strategic partnership aimed at providing even more value for dental professionals that purchase the Picasso diode dental laser.
STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project. The CAST is comprised of eight prominent cataract/refractive surgeons from across the United States who since June 2009 have implanted more than 300 eyes with the STAAR nanoFLEX intraocular lens (IOL) for the treatment of cataracts.
The CX-1 is the First Fully Hybrid Digital Retinal Camera from Canon and the World’s First Digital Non-Mydriatic Retinal Camera to Take FAF Photography
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.